Woonsocket, RI, USA – October, 2024 – CVS Health (NYSE: CVS) has announced the appointment of David Joyner as its new President and Chief Executive Officer, effective October 17, 2024. Joyner replaces Karen Lynch, who stepped down in agreement with the company’s Board of Directors. Alongside this leadership transition, Roger Farah, currently Chairman of the Board, will now serve as Executive Chairman.
Joyner, who also joins CVS Health’s Board of Directors, was most recently Executive Vice President, CVS Health and President, CVS Caremark. In these roles, he led the pharmacy services business, providing solutions to employers, health plans, and government entities while serving approximately 90 million members across Caremark, CVS Specialty, and other divisions.
With 37 years of experience in healthcare and pharmacy benefit management, Joyner has served on the boards of several private equity-backed healthcare companies. He began his career at Aetna as an employee benefit representative before joining Caremark Prescription Services as a regional sales manager. His career trajectory includes roles as Executive Vice President of Sales and Account Services at CVS Caremark and Executive Vice President of Sales and Marketing at CVS Health.
Roger Farah, Executive Chairman of CVS Health, remarked on the transition: “The Board believes this is the right time to make a change, and we are confident that David is the right person to lead our company for the benefit of all stakeholders, including customers, employees, patients, and shareholders. CVS Health is responsible for improving health for millions of people across the U.S., and our integrated businesses work together to deliver on our purpose and mission every day. To build on our position of strength, we believe David and his deep understanding of our integrated business can help us more directly address the challenges our industry faces, more rapidly advance the operational improvements our company requires, and fully realize the value we can uniquely create.”
“There is no greater honor than to lead a company whose mission and purpose are completely focused on improving health,” said David Joyner. “I came back to CVS Health in 2023 because I believed I could give more to the company, and I take this opportunity today for the same reason. I am proud to continue working side by side with our 300,000 colleagues who are building a world of health around every consumer. Every day, CVS Health expands access, drives greater affordability, and achieves better health outcomes for more than 186 million people. Aligned with our management team and our Board, I believe in the future of our company and I am committed to delivering our best every day to everyone we serve.”
Roger Farah also acknowledged Karen Lynch’s contributions: “The Board also recognizes the many contributions Karen made to our company, both during her tenure at Aetna and then as President and CEO of CVS Health. We are grateful for her consistent, customer-focused leadership, especially during the COVID-19 pandemic when our pharmacies provided needed tests and vaccines. We also appreciate her work to advance CVS Health’s modernization and transformation to become a diversified, connected, technology-driven healthcare company, allowing us to do even more for the people we are privileged to serve.”
About CVS Health:
CVS Health® is a leading health solutions company, reaching more people and improving the health of communities across America through its local presence, digital channels, and over 300,000 dedicated colleagues. CVS Health provides services such as chronic disease management, medication adherence, and affordable wellness services. It helps individuals navigate the healthcare system by improving access, lowering costs, and being a trusted partner in health.
Read Also : Imagination in a Disrupted Age: Navigating the Future with Curiosity and Empathy
